Use of H+, K+ - ATPase inhibitors for the treatment of nasal polyps

摘要

The present relates to the use of an He+, Ke+-ATPase inhibitor for the preparation of a medicament for the treatment of nasal polyps and for the treatment of Widal's Syndrome as well as the use of the He+, Ke+-ATPase inhibitor along with a glucocorticoid for the preparation of a pharmaceutical composition intended for simultaneous, separate or sequential administration in the treatment of Widal's Syndrome. There is also disclosed a pharmaceutical composition containing the above-indicated He+, Ke+-ATPase inhibitor and the glucocorticoid and intended for the treatment of Widal's Syndrome